Global Self Injection Device Market Insights Forecasts to 2033.

• The Global Self Injection Device Market Size was Valued at USD 6.5 Billion in 2023.
• The Market Size is Growing at a CAGR of 5.11% from 2023 to 2033.
• The Worldwide Self Injection Device Market Size is Expected to Reach USD 10.7 Billion by 2033.
• Europe is expected to grow the fastest during the forecast period.

Get more details on this report -

Request Free Sample PDF

The Global Self Injection Device Market Size is Anticipated to Exceed USD 10.7 Billion by 2033, Growing at a CAGR of 5.11% from 2023 to 2033.

 

Market Overview

A self-injection device is customized equipment made to help people give self-medicine on their own, without the help of a healthcare professional. These devices are especially helpful for individuals with chronic diseases, including diabetes, multiple sclerosis, rheumatoid arthritis, or specific hormone deficits, who need to self-administer drugs on a regular basis. Auto-injectors, pen injectors, and pre-filled syringes are just a few of the self-injection devices available; each is designed to accept a specific type and amount of medication. Typically, they have ergonomic designs with easy-to-handle mechanics, accurate dose management, and safety measures to guard against needle-related accidents. By enabling patients to simply manage their treatment regimens, these devices improve patients' independence and quality of life while guaranteeing precise and timely medicine administration. In addition, the growing number of regulatory approvals, the growing inclination toward medication self-administration, and the benefits of usability are expected to drive the rise. Major factors expected to promote market expansion include government backing, advantageous reimbursements, and technical improvements in self-injection devices.

 

Report Coverage

This research report categorizes the market for the global self injection device market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global self injection device market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global self injection device market.

 

Driving factor

The global self-injection device market is driven by various factors, including innovation and technical improvement. The sharp rise in spending per capita income is also driving market expansion. The market for self-injections is expanding due to a number of variables, including increased disposable income and growing diabetes incidence rates. Eliminating the necessity of routinely visiting a clinic or hospital for injections would also guarantee robust industry growth throughout the projected timeframe. In addition, self-injection technologies provide for higher repeatability and are comparatively more rapid. Devices like these reduce the amount of medication needed, which eventually results in better patient compliance, especially for elderly patients. Needle-free injectors, such as jet injectors, are easy to use in home care settings, successful, convenient, and associated with fewer hospital visits and total healthcare expenses. They also improve patient compliance. Therefore, it is expected that the growing benefits connected to self-injection devices will promote market expansion as a whole.

 

Restraining Factors

The market for self-injections will grow only to the extent that it is able to due to factors such as injection sterility, lack of knowledge of such devices, and the strict regulatory framework for regulatory agencies to approve new devices.

 

Market Segmentation

The Global Self Injection Device Market share is classified into product, usability and application.

• The pen injector segment is expected to hold the largest share of the global self injection device market during the forecast period.   

Based on the product, the global self injection device market is divided into auto injectors, needle-free injectors, pen injectors and others. Among these, the pen injector segment is expected to hold the largest share of the global self injection device market during the forecast period. Because to their widespread use and great efficiency. Pen injectors are essentially highly modified syringes that are used for precise and dependable delivery of biotech chemicals like insulin and human growth hormone. The invention of pen injectors has greatly increased patient convenience and ease of medication administration, driving up demand for the product throughout the projection period. Patients in developing nations are becoming more conscious of the significance of pen injectors because to the increase in acute and chronic illnesses.  

 

• The disposable segment is expected to hold the largest share of the global self injection device market during the forecast period.   

Based on the usability, the global self injection device market is divided into disposable, reusable. Among these, the disposable segment is expected to hold the largest share of the global self injection device market during the forecast period. The market for disposable self-injection devices has grown quickly due to growing concerns about the risks of needle stick injuries and increased knowledge of the advantages provided by drug delivery systems. For frequent, low-volume injections or changing dosage, these devices are practical. Many businesses, including BD, Gerresheimer AG, and Ypsomed AG, have launched cutting-edge goods in an effort to take a commanding share of the market.

 

• The cancer segment is expected to hold the largest share of the global self injection device market during the forecast period.   

Based on the application, the global self injection device market is divided into cancer, pain management and others. Among these, the cancer segment is expected to hold the largest share of the global self injection device market during the forecast period. During the projected period, there is expected to be an increase in demand for self-injection devices due to the rising prevalence of cancer. The increasing trend of cancer patients administering their own medications is anticipated to support the segment's expansion.    

 

 Regional Segment Analysis of the Global Self Injection Device Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

  

North America is anticipated to hold the largest share of the global self injection device market over the predicted timeframe  

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the largest share of the global self injection device market over the predicted timeframe. Because of a sedentary lifestyle, expensive medical expenses, an aging population, and a high prevalence of autoimmune disease recurrence. It is anticipated that the market would expand more quickly due to factors including the increased prevalence of chronic and lifestyle-related disorders and the existence of advanced healthcare infrastructure. Furthermore, it is anticipated that the local presence of significant U.S. market companies like Ypsomed AG and Becton, Dickinson and Company (BD) would fuel regional growth.  

 

Europe is expected to grow the fastest during the forecast period. Self-injection devices are predicted to become more popular among medical professionals as chronic illnesses become more common. Because of the region's established healthcare infrastructure and plenty of competent personnel, profitable expansion is anticipated during the projection period.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global self injection device along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Ypsomed AG
• BD
• Gerresheimer AG
• Antares Pharma
• Haselmeier AG
• NuGen Medical Devices
• Owen Mumford Ltd
• SHL Medical AG
• Pfizer, Inc.
• Amgen 
• Others.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In September 2023, Ypsomed and Novo Nordisk established a long-term supply arrangement for bulk autoinjectors.

 

• In October 2023, the FDA authorized Enable Injections to utilize their enFuse injector to administer Empaveli. Apellis Pharmaceuticals markets Empaveli, a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Self Injection Device Market based on the below-mentioned segments: 

 

Global Self Injection Device Market, By Product

• Auto Injectors
• Needle-Free Injectors
• Pen Injectors
• Others

 

Global Self Injection Device Market, By Usability

• Disposable
• Reusable

 

Global Self Injection Device Market, By Application

• Cancer
• Pain Management
• Others

 

Global Self Injection Device Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa